Moleculin Biotech
MBRX0.37366.60% ( -0.0264 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Moleculin Biotech(MBRX) predict that the EBIT is -7.874 M (-32.49%), Miss estimate;the EPS is -3.54 (+79.48%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B32.49%
-0.01B23.52%
-0.00B8.97%
EPSMiss expectations
-3.5479.48%
-1.663390.36%
-1.876710.88%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf